# Jiayuan Capital

> Jiayuan Capital is a VC fund in Futian backing Medical, Manufacturing and Biopharma. See 14 investments, check sizes, portfolio. Updated Sep 2026.

- Type: VC Fund
- Location: Futian, China
- Total investments: 14
- Last investment: Aug 2025
- Lead investor: 14%
- Last updated: Sep 2026
- Website: http://www.grandwaycapital.cn

Jiayuan Capital is a VC fund in Futian focused on Medical and Manufacturing. Jiayuan Capital invests in technological innovation and biomedicine.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 21% |
| Manufacturing | 3 | 21% |
| Biopharma | 2 | 14% |
| Automotive | 2 | 14% |
| Health Care | 2 | 14% |

29 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 36% |
| Series B | 5 | 36% |
| Angel | 2 | 14% |
| Series C | 1 | 7% |
| Equity Crowdfunding | 1 | 7% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mindflow | Mindflow is a service provider of AI data labeling and collection, focusing on the use of AI and data analysis to provide solutions. The data-driven AI infrastructure, with a data intelligence platform, helps enterprises to obtain digital intelligence operations. They provide general AI solutions from strategy to technology implementation, coveringthe data layer to the algorithm layer, empowering digital and intelligent enterprises. | $13.9M | Series B | Aug 08, 2025 |  |
| Yanwai Technology | Yanwai Technology is a developer and manufacturer of electric multi-functional camper cars , focusing on innovative outdoor products and their supporting equipment. |  | Series A | Jul 21, 2025 |  |
| ChengTech | Chengtai Technology is a smart car radar R&D company specializing in the research and development of 77G millimeter wave radar technology, and is committed to providing core technology and device solutions for the wireless communication, smart car and robot industries. |  | Series C | May 26, 2025 |  |
| Enjosim | Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals. It currently sells a variety of high-precision pen injectors designed for biologics such as insulin, growth hormone, and GLP-1. |  | Series A | Sep 09, 2024 |  |
| Tachem | Tachem is a biotechnology company that specializes in the research, development, production, and distribution of products from the protected amino acid series. | $42.3M | Series A | Nov 29, 2023 |  |
| QL Biopharma | QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases. | $28M | Series B | Nov 27, 2023 |  |
| Origin Quantum | Origin Quantum is a full-stack quantum computing company. | $147.8M | Series B | Jul 21, 2022 |  |
| HotMaxx | HotMaxx operates a chain of discount stores that offer products across multiple categories. The company sources goods from thousands of cooperating brands and makes them available through its wide store network. Products include global snacks such as chocolate and cookies. The stores also sell beverages like milk tea and coconut water. Ready-to-eatmeals such as beef noodles and packaged ramen are part of the selection. Household products, including lip balm and travel-sized shampoo, are available for daily use. HotMaxx also provides mother and baby supplies such as diapers and toys for children. |  | Series B | Aug 01, 2021 |  |
| Shenzhen eMeet Technology | Founded in 2016, EMEET is a high-tech enterprise focused on AI-Powered imaging. By combining cutting-edge audio-video processing with AI technologies, EMEET has secured more than 200 core patents worldwide and delivers comprehensive imaging solutions for live streaming, content creation, video conferencing, and other professional scenarios. |  | Equity Crowdfunding | Jun 30, 2021 |  |
| Jyss Bio | Jyss Bio is a developer of disposable bioreactors and peripheral equipment. |  | Series A | May 05, 2021 |  |

10 of 14 investments shown.

## Co-investors
- [Jiayuan Capital Management](https://shizune.co/investors/profile/jiayuan-capital-management) — VC Fund, 6 deals together
- [BRV](https://shizune.co/investors/profile/blue-run-ventures-china) — VC Fund, 1 deal together
- [BOC Capital](https://shizune.co/investors/profile/boc-capital) — VC Fund, 1 deal together
- [CAS Investment Management](https://shizune.co/investors/profile/cas-investment-management) — VC Fund, 1 deal together
- [CCB International](https://shizune.co/investors/profile/ccb-international) — VC Fund, 1 deal together
- [Chengdu Science and Technology Venture Capital](https://shizune.co/investors/profile/chengdu-science-and-technology-venture-capital-group) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Jiayuan Capital invest in?

Jiayuan Capital invests primarily in Medical, Manufacturing and Biopharma startups, most often at Series A and Series B stage. Most of the 14 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jiayuan Capital last invest?

The most recent investment recorded for Jiayuan Capital closed in Aug 2025. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co